Author:
Vijayvergia Namrata,Mehra Ranee
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference83 articles.
1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
2. NCI Surveillance Epidemiology and End Results. From http://seer.cancer.gov/statfacts/html/lungb.html#survival . Accessed March 2014
3. Li Y, Ye X, Liu J, Zha J, Pei L (2011) Evaluation of EML4–ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors. Neoplasia 13:1–11
4. Sharma SV, Fischbach MA, Haber DA, Settleman J (2006) “Oncogenic shock”: explaining oncogene addiction through differential signal attenuation. Clin Cancer Res 12:4392s–4395s
5. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263:1281–1284
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献